Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Smilagenin

EU orphan designation number: EU/3/11/914   
Active ingredient: Smilagenin
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: QRC Consultants Ltd.
Silvaco Technology Centre, Compass Point, St Ives, Cambridgeshire PE27 5JL, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/2011 Centralised Orphan - Designation EMA/OD/043/11 (2011)7047 of 27/09/2011
18/10/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/043/11/T/01 (2013)6966 of 16/10/2013